Impact of pandemic fatigue on the spread of COVID-19: a
mathematical modelling study
Disheng Tang1,2, Wei Cao3*, Jiang Bian3, Tie-Yan Liu3, Zhifeng Gao3, Shun Zheng3, Jue Liu4*
Interdisciplinary Graduate Program in Quantitative Biosciences, Georgia Institute of Technology, Atlanta,
GA, USA. 2School of Earth and Atmospheric Sciences, Georgia Institute of Technology, Atlanta, GA,
USA. 3Microsoft Research Asia, Beijing, China. 4Department of Epidemiology and Biostatistics, School of
Public Health, Peking University, Beijing, China. *wei.cao@microsoft.com; jueliu@bjmu.edu.cn.

1

Abstract

In late-2020, many countries around the world faced another surge in number of confirmed cases of COVID19, including United Kingdom, Canada, Brazil, United States, etc., which resulted in a large nationwide and
even worldwide wave. While there have been indications that precaution fatigue could be a key factor, no
scientific evidence has been provided so far. We used a stochastic metapopulation model with a hierarchical
structure and fitted the model to the positive cases in the US from the start of outbreak to the end of 2020.
We incorporated non-pharmaceutical interventions (NPIs) into this model by assuming that the precaution
strength grows with positive cases and studied two types of pandemic fatigue. We found that people in most
states and in the whole US respond to the outbreak in a sublinear manner (with exponent k=0.5), while only
three states (Massachusetts, New York and New Jersey) have linear reaction (k=1). Case fatigue (decline in
people's vigilance to positive cases) is responsible for 58% of cases, while precaution fatigue (decay of
maximal fraction of vigilant group) accounts for 26% cases. If there were no pandemic fatigue (no case
fatigue and no precaution fatigue), total positive cases would have reduced by 68% on average. Our study
shows that pandemic fatigue is the major cause of the worsening situation of COVID-19 in United States.
Reduced vigilance is responsible for most positive cases, and higher mortality rate tends to push local people
to react to the outbreak faster and maintain vigilant for longer time.

As warned by researchers (1), the resurgence of COVID-19 happened around the world in late 2020 (2,3,4).
Some countries like Italy and Iran had a second wave earlier than most (5,6), while others such as United
States, United Kingdom and Canada experienced record-breaking cases (7). Take United States for
example, as of Dec 22, cases of the past two months already account for more than half (53%) of total cases
in the whole 2020. Even though there has been a significant decrease in COVID cases since 2021, it is
important to understand the mechanisms of the multiple waves and prevent potential shortages of
equipment, staff and beds in hospitals (8).
However, the principles behind the resurgence of COVID-19 remain a challenging problem. While many
studies on second wave focus on the optimal strategy for school opening or control measures (9,10),
compartment models with homogeneous mixing assumption, and other methods such as network and
spatial models usually explore the additional epidemic states (11,12) or the interaction structure (13) and
mostly overlook the resurgence. Although many public health experts have expressed their concerns that
pandemic fatigue could threaten global health and might be the reason of the surge (14,15,16), few studies
focused on quantifying its impact on the spread of coronavirus (17).
Here we adopted the hierarchical metapopulation model that has shown capable of characterizing recurrent
outbreaks and simulating real epidemics such as Severe Acute Respiratory Syndrome (SARS) (18). We
incorporated into it a precaution strength that varies based on recent positive cases and decays with time

due to pandemic fatigue and used the cases in United States as an example to conduct our modeling study.
We examined the mechanisms of the COVID-19 resurgence, and the explanations for its increasing
epidemic size. We explored the situations without pandemic fatigue, hoping to provide insights for
precaution strategy.

We fitted our model to the whole curve of daily positive cases of 22 states and the whole US cases between
March 4th and December 22nd, 2020, 7-day moving average is used to filter out the noise. Here we showed
the results of US and its five states and put the rest in the Supplementary Appendix. We ran 5000 trials
using hyperparameter optimization algorithm to find the optimal parameters. We found that the optimal
memory length and speed of response ğ‘˜ğ‘˜ found by optimization algorithm are correlated with death rate in
each state (Figure S1 in Supplementary Appendix), indicating that people in places with higher mortality
rate tend to react faster, and remember older outbreak(s) thus take NPIs for a longer time. As a result, there
are fewer waves in New York, New Jersey and Massachusetts where mortality rate is much higher than the
rest. We also found that there's a strong negative correlation between the time-varying reproduction number
and the fraction of vigilant group. This relation is true for all data sets (the rest in Supplementary
Appendix), and they even have close identical slopes with slightly different intercepts. This indicates that
the fraction of individuals taking NPIs controls the reproduction number and determines specific features of
the outbreak, including the size and number of waves.

A

B

C

Figure 1: Schematic of the hierarchy structure and features of model fitting
(A) An example of hierarchical structure with branching ratio ğ‘ğ‘ = 3 and total depth ğ‘™ğ‘™ =2. There are ğ‘ğ‘ ğ‘™ğ‘™ = 9 contexts
(circles) in this example, and within each context the mean field assumption holds true. An individual travels from

ğ‘‘ğ‘‘ğ‘–ğ‘–ğ‘–ğ‘–

âˆ’

context ğ‘–ğ‘– to ğ‘—ğ‘— with probability ğ‘ğ‘ğ‘–ğ‘–ğ‘–ğ‘– âˆ ğ‘’ğ‘’ ğœ‰ğœ‰ , where ğ‘‘ğ‘‘ğ‘–ğ‘–ğ‘–ğ‘– is the ultra-metric distance between contexts ğ‘–ğ‘– and ğ‘—ğ‘— and ğœ‰ğœ‰ is a
tunable parameter. ğ‘‘ğ‘‘ğ‘–ğ‘–ğ‘–ğ‘– is defined as the lowest level the subpopulations ğ‘–ğ‘– and ğ‘—ğ‘— share. For example, here ğ‘‘ğ‘‘12 =
1, ğ‘‘ğ‘‘24 = ğ‘‘ğ‘‘68 = 2. (B) Dynamic reproduction number against fraction of vigilant group for six example data sets: the
whole United States, Arizona, Georgia, Massachusetts, Oregon and Texas states. (C) Relative epidemic size of 100
model simulations over real data.

As Figure 1 shows, the epidemic size generated from our model is close to the real case, since most boxes
are centered around a relative ratio of 1. Even the single simulation of Oregon State with the largest ratio of
1.44 only has an epidemic size of 3.5%, leaving 96.5% of uninfected population. The ratio distributions for
the remaining are all within the range of [0.4, 1.5] (Figure S3 in Supplementary Appendix). Because of the
relatively close size, our model can simulate a complete estimated dynamical process and predict a longterm run of coronavirus outbreak with higher reliability, in contrary to traditional epidemic models in
which the simulated size is usually much larger than real scenario and the pandemic dies down fast mostly
due to the depletion of susceptible individuals.
Due to the stochasticity of this model, we ran 100 simulations for each optimal parameter setting. We found
that ğ‘˜ğ‘˜ = 1 is true only for Massachusetts, New York and New Jersey States, and ğ‘˜ğ‘˜ = 0.5 for the remaining.
This means that only these three states react to COVID-19 in a linear manner, while the response of others
is much slower. Figure 2 shows the small variations in different runs, while the average is quite close to the
real case. The largest relative fitting error (New York in appendix) is 40%, while the smallest (the whole
US) is 11%. It is obvious that the states with longer memory have smoother variations of vigilant group,
such as Massachusetts State with a 170-day memory. The long-haul fight against the coronavirus directly
leads to the absence of a second wave around August in these states, reducing potentially a considerable
amount of COVID cases. The growth in vigilant group is always several weeks later than positive cases
because of the averaging and sublinear response in many states. It is worth noticing that the vigilance
fraction ğ‘£ğ‘£(ğ‘¡ğ‘¡) already increased to nearly its maximal value ğ‘“ğ‘“(ğ‘¡ğ‘¡) in response to the first and smallest
outbreak, however due to case fatigue, a 10 times larger follow-up wave cannot even alarm an equal
number of people! This indicates that case fatigue probably takes most responsibility for the recordbreaking coronavirus wave in the US in late 2020.

A

B

C

D

E

F

Figure 2: Model fit of six data sets with a hierarchically structured population with branching ratio ğ’ƒğ’ƒ = ğŸ”ğŸ”, depth
ğ’ğ’ = ğŸ“ğŸ“, group size ğ’ğ’ = ğŸğŸğŸğŸğŸğŸ, transmission rate ğœ·ğœ· = 0.65 and recovery rate ğœ¸ğœ¸ = 0.2.
(A-F) Top panels are the fitting results, where bars correspond to the real data of the whole United States, Arizona,
Georgia, Massachusetts, Oregon and Texas respectively, red line is the average of 100 simulations with its 99%
confidence interval (CI). The bottom panels are the time-varying reproduction number and the vigilance fraction ğ‘ğ‘(ğ‘¡ğ‘¡)
with their 99% CIs.

In Figures S7 and S9, we showed that our model has some good predictive power: when predicting the
cases of following 15 days, its smallest error (the whole US) is merely 3.8%, while the largest (Wyoming)
is 56% and the average error is 23%. For predicting a longer future like the next 30 days, our model has a

larger average error of 75%. However, our prediction of the time of future outbreaks is still satisfactory,
which could provide valuable warning for potential waves.

To study the impact of pandemic fatigue on the spread of coronavirus, we explored the situations where
memory length is longer and precaution fatigue (decay in maximal vigilance fraction ğ‘“ğ‘“(ğ‘¡ğ‘¡)) or case fatigue
(decline in case-sensitivity ğ‘ğ‘(ğ‘¡ğ‘¡)) is smaller and even absent. Surprisingly, we found that the extension of
memory would not lead to a decline in epidemic size; on the contrary, it generated an increase in affected
number of individuals when memory length was larger enough to be considered as unlimited (see Figure 3
(G)). This indicated that longer memory is not always good-- when people remember waves long time ago,
averaging effect tend to make them think the upcoming wave is nothing terrible.
Nonetheless, we found both precaution and case fatigue are major reasons of the exceptionally large size of
COVID-19. With the increase of both lower bounds ğ‘™ğ‘™ğ‘“ğ‘“ and ğ‘™ğ‘™ğ‘ğ‘ , final epidemic size declined quite fast,
especially those data sets with extremely small original values, e.g., Arizona State in Figure 3 (I). Figure 3
(J) also showed that when there was no pandemic fatigue (ğ‘™ğ‘™ğ‘“ğ‘“ = ğ‘™ğ‘™ğ‘ğ‘ = 1), five out of six data sets would have
a more than 70% decrease in epidemic size. In Figure 3 (A-F) we can see that all data sets would have had
a much smaller outbreak if there were no decay in precaution strength, and the occurrence of COVID
fatigue is distinct in each scenario. In fact, of all 23 data sets used in this study, pandemic fatigue accounts
for 68% of total coronavirus cases on average. This indicates that COVID fatigue is the largest cause of the
worsening coronavirus situation in late 2020.

A

B

C

D

E

F

G

H

I

J

Figure 3: Impact of pandemic fatigue on the outbreak
(A-F) Original cases with pandemic fatigue and cases without pandemic fatigue for six data sets. Both curves are
plotted with 99% confidence interval. (G) Epidemic size against memory length ğ‘šğ‘š with 99% confidence interval.
Circles represent the original result, and triangles denote the situation where the memory is unlimited. The value of ğ‘šğ‘š
at the triangle is larger than the observation length for all data, thus can be regarded as unlimited memory. (H, I)
Epidemic size against the lower bounds ğ‘™ğ‘™ğ‘“ğ‘“ and ğ‘™ğ‘™ğ‘ğ‘ with 99% confidence interval. Circles are the original results, and
triangles show the situations where there were no precaution and case fatigue, respectively. (J) The decrease and

decrease ratio in epidemic size when there is no pandemic fatigue, i.e., ğ‘™ğ‘™ğ‘“ğ‘“ = ğ‘™ğ‘™ğ‘ğ‘ = 1. "X" signs correspond to the
absolute value of decrease while empty circles represent the decrease in ratio.

We incorporated NPIs into a hierarchical metapopulation model and considered two types of pandemic
fatigue: precaution and case fatigue. Using United States for example, we obtained fairly good fits of the
whole curve of positive cases between March and December 2020. We also found that the model could
predict the cases of several states in the next 15 days with good accuracy, and even though it overestimated
the cases in the next 30 days for some states, it was still able to predict the right timing of the upcoming
wave, providing valuable warnings for a long time ahead.
We found that the estimated reproduction number had a perfect negative correlation with the fraction of
individuals seeking to take NPIs. Although some states had different intercepts, they all had close slopes in
this correlation, meaning the variation in vigilant group had similar impact in each case. This finding
suggested that one effective control measure is to encourage people to take precaution measures. The
decline of early waves was caused by stronger precaution measures, and we found that the emergence of
larger follow-up waves originated from the decrease in vigilant group and decay in vigilance level, which
we interpreted as two signs of pandemic fatigue.
While other research focused on the fatigue of policy makers and health workers (19,20), our study
explored civilian-level COVID fatigue and suggested it is one of the major reasons behind the resurgence
of coronavirus. Although there has been significant decrease in COVID-19 cases since 2021 due to
effective preventive interventions such as vaccines, pandemic fatigue will only intensify in the near future
hence needs our attention to prevent potential resurgence.
However, there are some limitations to our model analysis. We assumed that the precaution strength only
decreases with time in the long-term, while there could be some temporary increase in the interim due to
stronger policies or higher productivity. For example, in many places personal protective equipment (PPE)
such as facemask, respirator and hand sanitizer were in extreme shortage during the early outbreak; but as
manufacturers continued to produce the equipment, more and more people gained access to PPE which
might result in a quick decrease in cases and a long period with the disease under control. This could
possibly be one major reason that our model fitted the cases in New York and New Jersey states with much
higher error than others.
Our model focused on the effect of NPIs in analysis of COVID-19, but didn't explore the impact of travel
restrictions. One of the major advantages of hierarchical metapopulation model is its contexts located in a
hierarchical structure with travelers to spread the disease from one to another, while mean-field assumption
is true within each subpopulation. This indicates that one possible strategy to control the spread of
pandemic influenza is to impose travel ban and keep the epidemic local. When most infected or susceptible
individuals got into the recovered state, the disease simply dies down. We merely used constant values for
both the number of expected infected travelers ğ‘ƒğ‘ƒ0 and travel distance tendency ğœ‰ğœ‰ due to high complexity,
however, there are likely to be better implementations of the model with higher efficiency or just more
computing power that might make it possible to study time-varying travel parameters.
Even though our model could fit the real cases well, we used only three states (susceptible, infected,
recovered) for the transmission model. There have been many studies using SEIR model or even more
compartments (21,22,11) and showed that their epidemic models can also have good fits. This suggests that
more compartments are worth trying if our model failed to fit more complicated curves of future cases.
In conclusion, our results show that COVID fatigue is a major reason behind the resurgence in coronavirus
cases. In order to prevent another outbreak of COVID-19 cases, we need to maintain vigilant and overcome
pandemic fatigue. This long-term war against SARS-CoV-2 is not over yet, we can never let our guard
down.

Methods

Transmission model and precaution with fatigue are the two main components of our model. We used SIR
model with a hierarchical structure as the transmission model, assuming that homogeneous mixing is true
withing each subpopulation, and individuals travel between contexts with a probability correlated with their
distance. We introduced a precaution strength that is only related to recent positive cases due to
underestimation of the disease, and gradually decays with time because of COVID fatigue. We studied
pandemic fatigue through caution and case fatigue, representing the decline in number of vigilant people
and individuals becoming numb to new confirmed cases. In order to test the predictive power of our model,
we partitioned the real cases into training set and test set, and ran 5000 trials to find the best fit on the
training data.
Transmission model
To consider the spatial spread of COVID-19, we used a stochastic metapopulation model with
subpopulations distributed in a hierarchical structure (18). Each subpopulation equally consists of ğ‘›ğ‘›
individuals, while the branching ratio ğ‘ğ‘ and total depth ğ‘™ğ‘™ together decide the number of groups (ğ‘ğ‘ ğ‘™ğ‘™ ).
Therefore, the total population of this model is ğ‘ğ‘ = ğ‘ğ‘ ğ‘™ğ‘™ Ã— ğ‘›ğ‘›. Figure 1 (A) shows an example of the
hierarchical structure.

All individuals except for one start as susceptible to SARS-CoV-2 infection, and the one initial infected
case is assigned to a random subpopulation. Within each local context, compartment model (SIR) with
transmission rate ğ›½ğ›½ and recovery rate ğ›¾ğ›¾ is adopted. At each timestep, each individual travels from context ğ‘–ğ‘–
âˆ’

ğ‘‘ğ‘‘ğ‘–ğ‘–ğ‘—ğ‘—

with probability ğ‘ğ‘ and enters a new context ğ‘—ğ‘— with probability ğ‘ğ‘ğ‘–ğ‘–ğ‘–ğ‘– âˆ ğ‘’ğ‘’ ğœ‰ğœ‰ , where ğ‘‘ğ‘‘ğ‘–ğ‘–ğ‘–ğ‘– is the ultra-metric
distance between contexts ğ‘–ğ‘– and ğ‘—ğ‘—, while ğœ‰ğœ‰ is a tunable parameter that controls the tendency of long-distance
traveling. Defined as the expected number of infected individuals leaving a single context over the mean
infectious period, ğ‘ƒğ‘ƒ0 basically controls how many potential spreaders there are and it has been shown by
Watts et al. (18) that ğ‘ƒğ‘ƒ0 â‰ˆ ğ‘ğ‘ğ‘ğ‘â€²ğ‘›ğ‘›/ğ›¾ğ›¾, where ğœ“ğœ“â€² is the expected normalized epidemic size for a compartment
model with reproduction number ğ‘…ğ‘…0 . In our model we used ğ›½ğ›½ = 0.65, ğ›¾ğ›¾ = 0.2, ğ‘ğ‘ = 6, ğ‘™ğ‘™ = 5, ğ‘›ğ‘› = 100
which constitute a total of 777600 individuals for all data set. Through our experiments we found that ğ‘ğ‘ and
ğ‘™ğ‘™ need to be large enough when fitting complicated spreading process of infectious disease and showed in
the results that our parameter settings enabled our model to simulate any scenario we encountered.
Precaution with fatigue
In order to incorporate the non-pharmaceutical interventions (NPIs) and COVID fatigue into this model, we
considered a group of vigilant individuals that seek to take precaution measures based on recent confirmed
COVID-19 cases, and assumed there are two types of fatigue, of which the first one is precaution fatigue
denoting less vigilant people and the second is case fatigue meaning lower vigilance level to new cases. We
defined the vigilant group below
ğ‘£ğ‘£(ğ‘¡ğ‘¡) = ğ‘“ğ‘“(ğ‘¡ğ‘¡) min ï¿½ï¿½ğ‘ğ‘(ğ‘¡ğ‘¡)

ğ‘˜ğ‘˜

âˆ‘ğ‘¡ğ‘¡ğœğœ=ğ‘¡ğ‘¡âˆ’(ğ‘šğ‘šâˆ’1) ğ¼ğ¼ (Ì‡ ğœğœ)
ï¿½ , 1ï¿½
ğ‘šğ‘šğ‘šğ‘š

where ğ‘“ğ‘“(ğ‘¡ğ‘¡) represents the maximal fraction of vigilant group at time ğ‘¡ğ‘¡, ğ‘ğ‘(ğ‘¡ğ‘¡)is the case-sensitive factor at
time ğ‘¡ğ‘¡, ğ¼ğ¼ (Ì‡ ğ‘¡ğ‘¡) is the new positive cases at time ğ‘¡ğ‘¡ and ğ‘˜ğ‘˜ controls how fast people react to new cases (sublinear,
linear or superlinear). Since interventions are usually adjusted regarding the epidemic situations over a
period, we used the average of new cases for ğ‘šğ‘š time steps to manage the intervention strength, where ğ‘šğ‘š
represents the memory length. When thereâ€™s an outbreak, the surge in ğ¼ğ¼ Ì‡(ğ‘¡ğ‘¡) will lead to an increase in ğ‘£ğ‘£(ğ‘¡ğ‘¡),
i.e., more people taking NPIs which makes the disease harder to spread. As the epidemic eases people start
to let their guards down and this is usually when a second wave attacks. It's obvious that if ğ‘“ğ‘“(ğ‘¡ğ‘¡) and ğ‘ğ‘(ğ‘¡ğ‘¡)
decline, there will be less vigilant people and they will become less sensitive to positive cases, leading to
fierce resurgence of cases. Therefore, ğ‘“ğ‘“(ğ‘¡ğ‘¡) corresponds to precaution fatigue while ğ‘ğ‘(ğ‘¡ğ‘¡) shows case fatigue.

We used reverse sigmoid functions both for ğ‘“ğ‘“(ğ‘¡ğ‘¡) and ğ‘ğ‘(ğ‘¡ğ‘¡) to emulate the phenomenon where fatigue
permeates slowly
ğ‘“ğ‘“(ğ‘¡ğ‘¡) = ğ‘“ğ‘“(0)
ğ‘ğ‘(ğ‘¡ğ‘¡) = ğ‘ğ‘(0)

ğ‘™ğ‘™ğ‘“ğ‘“ + ğ‘’ğ‘’
1 + ğ‘’ğ‘’

ğ‘¡ğ‘¡
ğ‘ ğ‘ ğ‘“ğ‘“

ğ‘¡ğ‘¡
ğ‘¢ğ‘¢ğ‘“ğ‘“ âˆ’
ğ‘ ğ‘ ğ‘“ğ‘“

ğ‘™ğ‘™ğ‘ğ‘ + ğ‘’ğ‘’
1 + ğ‘’ğ‘’

ğ‘¢ğ‘¢ğ‘“ğ‘“ âˆ’

ğ‘¡ğ‘¡
ğ‘¢ğ‘¢ğ‘ğ‘ âˆ’
ğ‘ ğ‘ ğ‘ğ‘

ğ‘¢ğ‘¢ğ‘ğ‘ âˆ’

ğ‘¡ğ‘¡
ğ‘ ğ‘ ğ‘ğ‘

where ğ‘™ğ‘™ğ‘“ğ‘“ and ğ‘™ğ‘™ğ‘ğ‘ are the relative lower bounds of ğ‘“ğ‘“(ğ‘¡ğ‘¡) and ğ‘ğ‘(ğ‘¡ğ‘¡), ğ‘¢ğ‘¢ğ‘“ğ‘“ , ğ‘¢ğ‘¢ğ‘ğ‘ and ğ‘ ğ‘ ğ‘“ğ‘“ , ğ‘ ğ‘ ğ‘ğ‘ controls when and how fast
these functions decay. In our model, pandemic fatigue (the decline in ğ‘“ğ‘“(ğ‘¡ğ‘¡) and ğ‘ğ‘(ğ‘¡ğ‘¡)) is a major reason of
the recent surge in cases. We showed the curves of ğ‘“ğ‘“(ğ‘¡ğ‘¡) and ğ‘ğ‘(ğ‘¡ğ‘¡) for each data set in Figure S4 in
Supplementary Appendix.
Based on the paper by Eksin et al. (23), we assumed that the same fraction of both susceptible and infected
individuals belongs to the vigilant group and take NPIs, and all of them cannot infect or get infected from
others. Therefore, the dynamics become
2

ğ›½ğ›½ï¿½1 âˆ’ ğ‘£ğ‘£(ğ‘¡ğ‘¡)ï¿½ğ‘†ğ‘†ï¿½1 âˆ’ ğ‘£ğ‘£(ğ‘¡ğ‘¡)ï¿½ğ¼ğ¼
ğ›½ğ›½ï¿½1 âˆ’ ğ‘£ğ‘£(ğ‘¡ğ‘¡)ï¿½ ğ‘†ğ‘†ğ‘†ğ‘†
ğ‘‘ğ‘‘ğ‘‘ğ‘‘
=âˆ’
=âˆ’
ğ‘ğ‘
ğ‘ğ‘
ğ‘‘ğ‘‘ğ‘‘ğ‘‘

where ğ‘£ğ‘£(ğ‘¡ğ‘¡) is the fraction of vigilant group in the whole population.
Data sources

Since we used United States for an example in our modeling study, we fitted a stochastic transmission
dynamic model to multiple publicly available data sets of positive cases in 22 states and the whole US. The
data we used is from "The COVID Tracking Project" https://covidtracking.com/ and is open to public. The
reason that we only used data of 22 states instead of all 50 in the United States is due to the incompleteness
of the remaining data, considering we focused on the time period between March 4th, 2020 and December
22nd, 2020.
Contributors
Tang DS collect the data, did the analyses, produced the tables, and wrote the first draft of the manuscript.
Cao W and Liu J conceived and designed the study. Bian J, Liu YT, Gao ZF, Zheng S, and Liu J revised
the manuscript. All authors have read, contributed to, and approved the final version of the manuscript.
Declaration of interests
We declare no competing interests.
Acknowledgments
This work was supported by the National Key Research and Development Project (2020YFC0846300).

References
1. Xu S, Li Y. Beware of the second wave of COVID-19. The Lancet. 2020; 395: p. 1321â€“1322.

2. Cacciapaglia G, Cot C, Sannino F. Second wave COVID-19 pandemics in Europe: a temporal
playbook. Scientific reports. 2020; 10: p. 1â€“8.
3. Tuite AR, Greer AL, De Keninck S, Fisman DN. Risk for COVID-19 Resurgence Related to Duration
and Effectiveness of Physical Distancing in Ontario, Canada. Annals of Internal Medicine. 2020.
4. Leung K, Wu JT, Liu D, Leung GM. First-wave COVID-19 transmissibility and severity in China
outside Hubei after control measures, and second-wave scenario planning: a modelling impact
assessment. The Lancet. 2020.
5. Bontempi E. The Europe second wave of COVID-19 infection and the Italy â€œstrangeâ€ situation.
Environmental Research. 2020;: p. 110476.
6. Ghanbari B. On forecasting the spread of the COVID-19 in Iran: The second wave. Chaos, Solitons &
Fractals. 2020; 140: p. 110176.
7. Organization WH, others. COVID-19 weekly epidemiological update, 24 November 2020. 2020.
8. Miller IF, Becker AD, Grenfell BT, Metcalf CJE. Disease and healthcare burden of COVID-19 in the
United States. Nature Medicine. 2020; 26: p. 1212â€“1217.
9. Panovska-Griffiths J, Kerr CC, Stuart RM, Mistry D, Klein DJ, Viner RM, et al. Determining the
optimal strategy for reopening schools, the impact of test and trace interventions, and the risk of
occurrence of a second COVID-19 epidemic wave in the UK: a modelling study. The Lancet Child &
Adolescent Health. 2020; 4: p. 817â€“827.
10. Aleta A, Martin-Corral D, y Piontti AP, Ajelli M, Litvinova M, Chinazzi M, et al. Modeling the
impact of social distancing, testing, contact tracing and household quarantine on second-wave
scenarios of the COVID-19 epidemic. medRxiv. 2020.
11. Hao X, Cheng S, Wu D, Wu T, Lin X, Wang C. Reconstruction of the full transmission dynamics of
COVID-19 in Wuhan. Nature. 2020; 584: p. 420â€“424.
12. Fanelli D, Piazza F. Analysis and forecast of COVID-19 spreading in China, Italy and France. Chaos,
Solitons & Fractals. 2020; 134: p. 109761.
13. Thurner S, Klimek P, Hanel R. A network-based explanation of why most COVID-19 infection curves
are linear. Proceedings of the National Academy of Sciences. 2020; 117: p. 22684â€“22689.
14. Cabrera J. As pandemic surges, officials call COVID-19 fatigue real and dangerous. 2021 Jan Jan.
https://www.kold.com/2021/01/04/pandemic-surges-officials-call-covid-fatigue-real-dangerous/.
15. Maddock J. Sick of COVID-19? Hereâ€™s why you might have pandemic fatigue. 2020 Oct.
https://theconversation.com/sick-of-covid-19-heres-why-you-might-have-pandemic-fatigue-148294.
16. Silva C, Martin M. U.S. Surgeon General Blames 'Pandemic Fatigue' For Recent COVID-19 Surge.
2020 Nov. https://www.npr.org/sections/coronavirus-live-updates/2020/11/14/934986232/u-ssurgeon-general-blames-pandemic-fatigue-for-recent-covid-19-surge.
17. Rahmandad H, Lim TY, Sterman J. Behavioral dynamics of COVID-19: estimating under-reporting,
multiple waves, and adherence fatigue across 91 nations. medRxiv. 2020 January.

18. Watts DJ, Muhamad R, Medina DC, Dodds PS. Multiscale, resurgent epidemics in a hierarchical
metapopulation model. Proceedings of the National Academy of Sciences. 2005; 102: p. 11157â€“
11162.
19. Gilbert JA. Seasonal and pandemic influenza: global fatigue versus global preparedness. The Lancet
Respiratory Medicine. 2018; 6: p. 94â€“95.
20. Sasangohar F, Jones SL, Masud FN, Vahidy FS, Kash BA. Provider burnout and fatigue during the
COVID-19 pandemic: lessons learned from a high-volume intensive care unit. Anesthesia and
analgesia. 2020.
21. Gatto M, Bertuzzo E, Mari L, Miccoli S, Carraro L, Casagrandi R, et al. Spread and dynamics of the
COVID-19 epidemic in Italy: Effects of emergency containment measures. Proceedings of the
National Academy of Sciences. 2020; 117: p. 10484â€“10491.
22. Giordano G, Blanchini F, Bruno R, Colaneri P, Di Filippo A, Di Matteo A, et al. Modelling the
COVID-19 epidemic and implementation of population-wide interventions in Italy. Nature Medicine.
2020;: p. 1â€“6.
23. Eksin C, Paarporn K, Weitz JS. Systematic biases in disease forecastingâ€“the role of behavior change.
Epidemics. 2019; 27: p. 96â€“105.

Supplementary appendix for
Impact of pandemic fatigue on the spread of COVID-19: a mathematical modelling study
Disheng Tang1, 2, Wei Cao3*, Jiang Bian3, Tie-Yan Liu3, Zhifeng Gao3, Shun Zheng3, Jue Liu4*
1

Interdisciplinary Graduate Program in Quantitative Biosciences, Georgia Institute of Technology, Atlanta, GA, USA
School of Earth and Atmospheric Sciences, Georgia Institute of Technology, Atlanta, GA, USA
3
Microsoft Research Asia, Beijing, China
4
Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China
2

*Correspondence to: wei.cao@microsoft.com, jueliu@bjmu.edu.cn

Appendix Contents

Supplementary Text....................................................................................................................................................... 2
Figure S1 ....................................................................................................................................................................... 3
Figure S2 ....................................................................................................................................................................... 4
Figure S3 ....................................................................................................................................................................... 5
Figure S4 ....................................................................................................................................................................... 6
Figure S5 ....................................................................................................................................................................... 7
Figure S6 ....................................................................................................................................................................... 8
Figure S7 ....................................................................................................................................................................... 9
Figure S8 ..................................................................................................................................................................... 10
Figure S9 ..................................................................................................................................................................... 11
Figure S10 ................................................................................................................................................................... 12
Figure S11 ................................................................................................................................................................... 13
Table S1 ....................................................................................................................................................................... 14
Table S2 ....................................................................................................................................................................... 15
Table S3 ....................................................................................................................................................................... 16
Table S4 ....................................................................................................................................................................... 17
Table S5 ....................................................................................................................................................................... 18
Table S6 ....................................................................................................................................................................... 19
References ................................................................................................................................................................... 20

Supplementary Text
Data
The COVID-19 data sets we used were from "The COVID Tracking Project" (1), the population data we
used was from World Population Review (2), we used positive cases and death cases from this data set (3)
Loss function
For model fitting and prediction, we used a commonly used hyperparameter optimization algorithm
named Hyperopt (4) to find the optimal parameters. We defined a simple loss function as the relative
absolute error
âˆ‘
ğ‘Œ ğ‘Œ
ğ‘™ğ‘œğ‘ ğ‘ 
âˆ‘ ğ‘Œ
ğ‘Œ

ğ‘Œ

ğ“…

where ğ‘‡ is the total length of data, ğ‘Œ is the actual number of cases at time ğ‘¡, ğ‘Œ is the predicted number of
cases at time ğ‘¡, ğ‘Œ represents the number of model cases at time ğ‘¡, ğ“… denotes the population of the data set
and ğ‘ is the total number of individuals in the model. Since we fixed the hierarchy structure, during
optimization we fitted the normalized data (cases/population), after we found the optimal parameters we
ğ“…
adjusted the predicted cases by multiplying a constant .
Hyperparameter space
For the expected number of infected travelers ğ‘ƒ and long-distance travel tendency ğœ‰, we used a suitable
range to make sure the spreading speed and final epidemic size are both in a proper scope. It's worth
noting that we set the range of ğœ‰ as [0ê4, 0ê5], with the upper bound a little lower than the theoretical
value

0ê558 that assumes people travel to all distances with equal likelihood (4), which is nearly

impossible in real life. The lower bound of ğœ‰ is to make sure thereâ€™s an outbreak.

A

B

Figure S1
(A) Memory length against death rate (total death cases over total positive cases) for United States and its 22 states.
The Pearson coefficient is 0.75 with a p-value of 4ê2 10 . (B) Speed of response ğ‘˜ against death rate. The
Pearson coefficient is 0.91 with a p-value of 1ê4 10 .

Figure S2
Reproduction number against precaution fraction for the remaining states.

Figure S3
Relative epidemic size of 100 model simulations over real data for the remaining data sets.

Figure S4
Decay functions determined by optimization algorithm in model fitting.

Figure S5
Model fitting results for the remaining states.

Figure S6
Time-varying reproduction number and the vigilance fraction ğ‘ ğ‘¡ with their 99% confidence intervals in model
fitting results for the remaining states.

Figure S7
15-day prediction results. Bars correspond to the real data, blue line is the average fitting result of 100 simulations
with 99% confidence interval (CI) while the red line is the predicted cases of the fitted model.

Figure S8
Time-varying reproduction number and the vigilance fraction ğ‘ ğ‘¡ with their 99% confidence intervals in 15-day
prediction results.

Figure S9
30-day prediction results. Bars correspond to the real data, blue line is the average fitting result of 100 simulations
with 99% confidence interval (CI) while the red line is the predicted cases of the fitted model.

Figure S10
Time-varying reproduction number and the vigilance fraction ğ‘ ğ‘¡ with their 99% confidence intervals in 30-day
prediction results.

Figure S11
Original cases with pandemic fatigue and cases without pandemic fatigue for the remaining states.

Table S1
Parameter space of Hyperopt optimization algorithm.
Parameter

Space

Type

ğ‘š

[10, 230]

integer/day (step of 10)

ğ‘ƒ

[5, 20]

integer

ğœ‰

[0ê4, 0ê5]

float

ğ‘“ 0

[0ê2, 0ê6]

float

ğ‘ 0

[6000, 15000]

integer (step of 100)

ğ‘™

[0ê1, 0ê9]

float

ğ‘™

[0ê1, 0ê9]

float

ğ‘¢

[6, 18]

float

ğ‘¢

[6, 18]

float

ğ‘ 

[10, 20]

float

ğ‘ 

[10, 20]

float

Table S2
Optimal parameters for fitting.
Country/
State

Memory
(Day)

ğ’Œ

ğ‘·ğŸ

ğƒ

ğ’‡ ğŸ

ğ’„ ğŸ

ğ’ğ’‡

ğ’ğ’„

ğ’–ğ’‡

ğ’–ğ’„

ğ’”ğ’‡

ğ’”ğ’„

US

60

0.5

7

0.494

0.587

6300

0.518

0.395

17.558

8.808

13.343

11.071

AZ

90

0.5

10

0.51

0.599

14800

0.301

0.125

14.712

6.003

19.63

12.615

CA

120

0.5

12

0.468

0.569

14500

0.436

0.324

13.415

6.515

18.203

14.799

CO

70

0.5

15

0.402

0.576

10200

0.853

0.112

6.599

16.792

19.224

12.769

FL

80

0.5

12

0.408

0.581

13400

0.537

0.114

17.78

7.694

18.794

11.036

GA

120

0.5

15

0.503

0.557

11500

0.776

0.276

15.159

9.933

13.831

10.356

IL

60

0.5

13

0.492

0.425

7600

0.886

0.211

17.573

17.802

15.919

11.762

IN

50

0.5

8

0.458

0.52

7200

0.809

0.1

9.312

15.468

11.634

14.001

MA

170

1

10

0.434

0.48

8800

0.6

0.174

17.768

15.312

18.785

17.829

MI

70

0.5

16

0.449

0.592

9000

0.745

0.201

17.983

13.047

13.226

15.911

NC

80

0.5

5

0.408

0.423

9400

0.353

0.291

15.677

8.809

17.472

11.509

NE

60

0.5

17

0.493

0.425

9100

0.747

0.125

16.997

11.775

19.484

17.362

NH

100

0.5

8

0.409

0.499

12400

0.478

0.323

13.653

15.216

18.899

15.078

NJ

160

1

8

0.432

0.426

7900

0.838

0.38

17.597

14.561

18.381

18.396

NY

180

1

16

0.48

0.406

13400

0.711

0.345

17.334

15.437

16.244

18.442

OR

50

0.5

9

0.481

0.58

15200

0.608

0.239

8.947

16.782

10.924

13.644

RI

50

0.5

17

0.497

0.42

8400

0.874

0.154

16.193

15.577

14.266

14.833

SC

80

0.5

6

0.473

0.583

13000

0.653

0.115

17.23

6.036

15.332

12.342

TX

70

0.5

8

0.503

0.56

9900

0.712

0.196

15.391

8.045

16.466

11.138

VA

80

0.5

10

0.43

0.452

12600

0.614

0.449

15.021

6.001

16.725

16.221

WA

60

0.5

11

0.436

0.567

11800

0.697

0.305

8.612

17.997

12.077

13.372

WI

70

0.5

10

0.434

0.554

9400

0.655

0.154

10.173

13.444

10.383

14.364

WY

100

0.5

16

0.484

0.572

14800

0.745

0.115

6.603

16.947

15.647

12.402

Table S3
Optimal parameters for 15-day prediction.
Country/
State

Memory
(Day)

ğ’Œ

ğ‘·ğŸ

ğƒ

ğ’‡ ğŸ

ğ’„ ğŸ

ğ’ğ’‡

ğ’ğ’„

ğ’–ğ’‡

ğ’–ğ’„

ğ’”ğ’‡

ğ’”ğ’„

US

50

0.5

11

0.438

0.55

7200

0.677

0.23

9.764

15.814

11.004

14.811

AZ

110

0.5

9

0.47

0.478

14300

0.723

0.208

11.236

7.757

19.126

10.236

CA

90

0.5

7

0.482

0.588

11400

0.537

0.234

15.84

6.007

15.345

16.087

CO

60

0.5

16

0.419

0.586

9100

0.797

0.123

7.802

16.605

10.307

13.108

FL

80

0.5

13

0.425

0.592

14300

0.475

0.124

17.553

7.999

18.704

11.055

GA

90

0.5

16

0.407

0.585

12500

0.807

0.244

8.448

8.395

18.583

11.017

IL

60

0.5

11

0.469

0.433

6800

0.511

0.192

17.117

17.876

17.442

11.915

IN

100

0.5

8

0.447

0.583

10100

0.471

0.366

17.92

6.215

12.042

16.962

MA

190

1

9

0.479

0.519

6200

0.383

0.845

14.016

15.753

19.242

18.567

MI

60

0.5

17

0.505

0.6

9500

0.768

0.1

14.659

12.698

19.82

16.332

NC

50

0.5

5

0.469

0.324

12600

0.711

0.535

14.832

7.092

15.799

11.843

NE

50

0.5

9

0.422

0.4

6600

0.875

0.169

11.798

17.316

16.652

12.348

NH

80

0.5

6

0.449

0.6

9200

0.636

0.122

13.271

15.006

19.783

15.431

NJ

180

1

13

0.468

0.411

8500

0.587

0.885

16.578

16.077

18.939

15.989

NY

190

1

8

0.442

0.517

10800

0.266

0.66

17.995

13.492

15.621

19.837

OR

50

0.5

5

0.432

0.573

14800

0.342

0.392

17.019

6.191

14.24

11.776

RI

50

0.5

16

0.452

0.422

7100

0.759

0.128

16.886

17.988

19.281

12.706

SC

100

0.5

5

0.416

0.34

7300

0.643

0.545

13.613

6.006

18.73

19.099

TX

70

0.5

7

0.439

0.587

11800

0.35

0.146

14.122

6.002

19.994

14.196

VA

50

0.5

5

0.487

0.403

6200

0.472

0.241

14.623

16.144

18.315

15.426

WA

70

0.5

12

0.406

0.58

14900

0.598

0.397

17.333

6.994

13.478

12.405

WI

60

0.5

7

0.481

0.569

7600

0.59

0.148

7.078

9.877

15.609

19.481

WY

70

0.5

6

0.405

0.6

6000

0.499

0.175

17.276

14.513

12.321

12.74

Table S4
Optimal parameters for 30-day prediction.
Country/
State

Memory
(Day)

ğ’Œ

ğ‘·ğŸ

ğƒ

ğ’‡ ğŸ

ğ’„ ğŸ

ğ’ğ’‡

ğ’ğ’„

ğ’–ğ’‡

ğ’–ğ’„

ğ’”ğ’‡

ğ’”ğ’„

US

80

0.5

19

0.467

0.572

11000

0.652

0.377

11.884

6.484

19.114

13.853

AZ

90

0.5

14

0.469

0.591

14300

0.385

0.142

17.586

8.471

19.823

10.189

CA

90

0.5

11

0.492

0.578

12600

0.836

0.263

12.796

7.899

17.888

11.696

CO

50

0.5

10

0.446

0.397

14300

0.594

0.899

14.966

15.644

13.869

14.223

FL

90

0.5

11

0.4

0.589

14400

0.318

0.113

17.976

8.327

18.922

10.011

GA

100

0.5

8

0.424

0.554

12900

0.13

0.167

14.372

6.477

19.695

13.384

IL

60

0.5

12

0.473

0.49

6000

0.343

0.283

14.561

12.267

17.612

17.779

IN

50

0.5

8

0.4

0.447

7400

0.485

0.42

12.536

14.86

15.823

17.002

MA

180

1

16

0.423

0.422

8500

0.776

0.602

12.429

17.283

19.321

17.233

MI

60

0.5

18

0.449

0.592

7600

0.52

0.505

16.666

16.157

13.373

14.148

NC

50

0.5

5

0.402

0.577

8600

0.641

0.173

12.927

6.824

19.191

12.378

NE

50

0.5

8

0.409

0.403

6200

0.527

0.734

17.009

12.926

12.233

14.335

NH

80

0.5

6

0.514

0.523

12000

0.151

0.324

13.556

13.618

18.893

19.441

NJ

200

1

10

0.492

0.392

10200

0.643

0.503

14.692

16.027

19.006

15.417

NY

190

1

17

0.485

0.417

13500

0.869

0.702

13.66

15.066

18.831

19.502

OR

70

0.5

5

0.451

0.586

13500

0.413

0.336

13.341

8.916

17.808

12.23

RI

60

0.5

16

0.446

0.424

8900

0.883

0.1

17.382

12.423

14.176

17.974

SC

60

0.5

7

0.486

0.564

12600

0.318

0.129

15.815

8.03

19.136

10.309

TX

80

0.5

5

0.485

0.588

14900

0.321

0.101

14.93

7.326

18.267

10.404

VA

50

0.5

8

0.441

0.402

9500

0.629

0.771

12.8

8.628

18.981

13.114

WA

90

0.5

11

0.422

0.584

12200

0.548

0.47

11.696

7.875

19.243

11.435

WI

50

0.5

6

0.445

0.396

7800

0.6

0.236

14.339

12.395

12.097

16.443

WY

50

0.5

13

0.473

0.562

14300

0.53

0.576

8.524

15.156

18.83

14.644

Table S5
Loss and prediction error. It is worth noticing that fitting loss and fitting error are calculated in the same way, they
are different because we used 100 simulations for the fitting error and only 1 simulation when fitting to obtain the
results faster. The loss of prediction is the relative error on training data and error of prediction is for the test data.
Loss
Country/
State

Fitting

Fitting/Prediction error

15-day
prediction

30-day
prediction

Fitting

15-day
prediction

30-day
prediction

US

0.104137

0.116895

0.126069

0.113338

0.037656

0.243436

AZ

0.140132

0.189093

0.15417

0.161838

0.158821

0.398501

CA

0.129862

0.185445

0.139849

0.203179

0.27438

0.541546

CO

0.116441

0.141972

0.13189

0.12919

0.069189

2.041213

FL

0.141804

0.148544

0.138909

0.17923

0.143377

0.088011

GA

0.113013

0.120552

0.13754

0.120177

0.255078

0.603337

IL

0.120467

0.13473

0.127611

0.15181

0.340834

2.856132

IN

0.108787

0.144528

0.142557

0.114343

0.426366

1.017165

MA

0.2308

0.268249

0.23956

0.30022

0.122239

0.308559

MI

0.124433

0.146739

0.166666

0.156004

0.19805

1.286533

NC

0.131524

0.130896

0.121064

0.202857

0.10792

0.309793

NE

0.157849

0.133618

0.117156

0.181537

0.261076

2.4819

NH

0.153167

0.184409

0.195939

0.181314

0.144823

0.23976

NJ

0.28886

0.301811

0.342541

0.397115

0.471214

0.521886

NY

0.343875

0.41733

0.424103

0.386519

0.174586

0.545011

OR

0.201118

0.167437

0.175524

0.249777

0.146319

0.157438

RI

0.171179

0.208159

0.221826

0.195057

0.096112

0.237852

SC

0.15877

0.184725

0.158167

0.157753

0.190083

0.290729

TX

0.172924

0.166649

0.173168

0.18079

0.082429

0.198579

VA

0.147754

0.16851

0.152001

0.123144

0.515294

0.111637

WA

0.169515

0.154493

0.174063

0.214338

0.237382

0.233014

WI

0.127011

0.140602

0.124947

0.134108

0.315959

1.511313

WY

0.156797

0.170929

0.12378

0.146702

0.561999

1.098091

Table S6
The reduction in epidemic size (ratio) when there is no precaution fatigue (ğ‘™
ğ‘™
1).
pandemic fatigue (ğ‘™

1), case fatigue (ğ‘™

Country/
State

Precaution fatigue

Case fatigue

Pandemic fatigue

US

0.427735

0.553156

0.728053

AZ

0.197273

0.860263

0.879869

CA

0.563515

0.514755

0.803936

CO

0.245888

0.71931

0.773996

FL

0.010145

0.858118

0.85911

GA

0.297297

0.591242

0.711272

IL

0.053935

0.548937

0.557762

IN

0.314332

0.65999

0.749428

MA

0.014687

0.358541

0.364546

MI

0.320236

0.633773

0.702873

NC

0.193906

0.633159

0.696993

NE

0.016793

0.641908

0.64377

NH

0.381958

0.4809

0.63397

NJ

0.015376

0.269503

0.274515

NY

0.108521

0.196425

0.287904

OR

0.602456

0.343861

0.762766

RI

0.154112

0.497906

0.568918

SC

0.152911

0.855742

0.875037

TX

0.177496

0.764332

0.798741

VA

0.261333

0.485733

0.61707

WA

0.457615

0.343483

0.627648

WI

0.546159

0.680024

0.847954

WY

0.425078

0.79714

0.869849

1) or

References
1. Atlantic Monthly Group. The COVID Tracking Project. [Online].; 2020 [cited 2020 12 22. Available from:
https://covidtracking.com/data/download.
2. World Population Review. World Population Review. [Online].; 2020 [cited 2020 12 22. Available from:
https://worldpopulationreview.com/states.
3. Hale T, Webster S. Oxford COVID-19 government response tracker. 2020.
4. Bergstra J, Yamins D, Cox D. Making a science of model search: Hyperparameter optimization in hundreds of
dimensions for vision architectures. In International conference on machine learning; 2013. p. 115â€“123.
5. Watts DJ, Muhamad R, Medina DC, Dodds PS. Multiscale, resurgent epidemics in a hierarchical metapopulation
model. Proceedings of the National Academy of Sciences. 2005; 102: p. 11157â€“11162.

